In June 2019, the ICH Assembly met in Amsterdam, the Netherlands for its bi-annual meeting. To ensure transparency in the ICH process, minutes from this meeting are made publicly available so that all stakeholders can be informed on important decisions and real-time progress of the development of ICH Guidelines.

ICH is announcing a public meeting entitled “ICH Global Meeting on E8(R1) Guideline on General Considerations for Clinical Trials”, to be held on October 31, 2019 at 08:30 a.m. to 5:00 p.m. ET in Silver Spring, Maryland, USA, with Webcast option available.

The MedDRA Management Committee noted that 1 March 2019 marked the 20th anniversary of the first release of MedDRA. From its beginning, starting with 254 subscribers in 1999, MedDRA has experienced remarkable growth with currently over 5,700 subscribing organisations...

The International Council for Harmonisation (ICH) met in Amsterdam, the Netherlands from 1 – 6 June 2019. The meeting marked ICH’s largest biannual meeting to-date, bringing together almost 500 participants from ICH’s sixteen Members and twenty-eight Observers.

The ICH E8(R1) draft Guideline on General Considerations for Clinical Studies reached Step 2b of the ICH Process in May 2019 and now enters the consultation period. Additionally, a Step 2 Informational Presentation has also been developed by the Expert Working Group.

The ICH E8(R1) draft Guideline on General Considérations for Clinical Trials reached Step 2b of the ICH Process in May 2019 and has entered the public consultation period.

ICH is conducting a Call for Expression of Interest for ICH Training Associates with a view to exploring the possibility of contracting appropriate accredited non-profit training organisations/institutions

The ICH Q3D(R1) Guideline reaches Step 4 of the ICH Process

Publication of the ICH M10 draft Guideline and Presentation

In November 2018, the ICH Management Committee met in Charlotte, NC, USA for their bi-annual meeting.